Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway.


Adiponectin is a peptide hormone secreted by adipose tissue. It is a key hormone responsible for insulin sensitization, and its circulating level is inversely associated with abdominal obesity. Recent studies have shown that a reduced plasma adiponectin level is significantly correlated with the risk of various cancers. However, there are few studies regarding the association of adiponectin and colorectal cancer. To address this issue, we investigated the effect of adiponectin on colorectal cancer cells. Three colorectal cancer cell lines express both AdipoR1 and AdipoR2 receptors. MTT assay revealed that adiponectin inhibited human colorectal cancer cell growth. Furthermore, Western blot analysis revealed that adiponectin activated adenosine monophosphate-activated protein kinase (AMPK) and suppressed mammalian target of rapamycin (mTOR) pathways. Selective AMPK inhibitor compound C abrogated the inhibitory effect of adiponectin on cell growth. Our results clearly demonstrate the novel findings that adiponectin inhibits colorectal cancer cell growth via activation of AMPK, thereby down-regulating the mTOR pathway.

4 Figures and Tables

Citations per Year

621 Citations

Semantic Scholar estimates that this publication has 621 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Sugiyama2009AdiponectinIC, title={Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway.}, author={Michiko Sugiyama and Hirokazu Takahashi and Kunihiro Hosono and Hiroki Endo and Shingo Kato and Kyoko Yoneda and Yuichi Nozaki and Koji Fujita and Masato Yoneda and Koichiro Wada and Hitoshi Nakagama and Atsushi Nakajima}, journal={International journal of oncology}, year={2009}, volume={34 2}, pages={339-44} }